Monitor for any upcoming corporate events (earnings, pipeline updates, or regulatory news) that may have motivated the concentrated selling. The cluster is not large enough to be a standalone bearish catalyst, but combined with the recent selling pattern, it suggests insiders may be reducing exposure ahead of potential headwinds.
KRYS drugs
KRYS drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 8 $351.26entry
- T+1 · 2mo ago −0.90%α −0.44% · $348.09
- T+5 · 2mo ago −4.15%α −3.03% · $336.68
- T+20 · 6w ago −6.96%α −8.67% · $326.81
- T+49 · todayOpen
- T+60 · in 15d Pending
Price Chart
How similar events traded
Executive Summary
Two top executives at Krystal Biotech (CEO Krish S. Krishnan and President of R&D Suma Krishnan) sold a combined ~$12.8M of stock on September 4, 2026, in a one-day cluster. The sales represent 0.12% of the $11.0B market cap, a modest but notable amount, and follow a pattern of recent insider selling ($6.9M over the prior 30 days). While not alarming at this scale, the simultaneous C-suite selling warrants attention for any upcoming negative catalyst.
Key Financial Metrics
Key Facts
- CEO Krish S. Krishnan sold ~$3.86M in 7 open-market transactions on Sept 4, 2026.
- President of R&D Suma Krishnan sold ~$8.98M in 13 open-market transactions on the same day.
- Total cluster value ~$12.84M, or 0.12% of KRYS's $11.0B market cap.
- Both insiders are C-suite, increasing the signal weight of the selling cluster.
- Prior 30-day insider activity showed 10 sells totaling $6.9M, indicating an ongoing selling pattern.
Financial Impact
~$12.8M in insider sales, representing 0.12% of market cap
Risk Factors
- Further insider selling could accelerate if negative news emerges.
- The cluster may indicate management's reduced confidence in near-term prospects.
- No 10b5-1 plan disclosure was provided, raising the possibility of discretionary sales.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KRYS-1788563789342 |
Track record
18 reports on KRYS
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +26.60% at T+60 after the May 4, 2026 report. 5 of 6 went positive at some point.
Filters
- Nov 2, 202614d ago 8-K Bullish 6/10 No price data
- Nov 2, 202614d ago Press Release Bullish 6/10 Entry $295.90 Now $297.90 +0.68% settles Dec 1
- Oct 30, 202617d ago SC 13G/A Bearish 5/10 Entry $332.29 Now $297.90 +10.35% settles Nov 30
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $321.42 Now $297.90 −7.32% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $321.42 Now $297.90 −7.32% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $320.13 Now $297.90 −6.94% settles Nov 19
- Oct 21, 202626d ago Institutional Cluster Neutral 3/10 Entry $320.13 Now $297.90 −6.94% settles Nov 19
- Oct 15, 20264w ago 8-K Bullish 6/10 Entry $330.00 to $305.68 Now $297.90 −9.73% ▼ −7.37% −5.47% vs SPY
- Sep 4, 202610w ago Insider Cluster Bearish 5/10 Viewing Entry $351.26 to $326.81 Now $297.90 +15.19% ▲ +6.96% +8.67% vs SPY
- Aug 14, 202613w ago 144 Neutral 2/10 Entry $335.73 to $336.68 Now $297.90 −11.27% ▲ +0.28% +2.26% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers